A Multicenter, Randomized, Open Label Trial of a New Animal Extracted Surfactant to Treat RDS in Preterm Infants
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of the new pulmonary
surfactant produced by Butantan Institute among premature infants with gestational age below
34 weeks with RDS, comparing to the pulmonary surfactants commercially available in Brazil.